LifeScience Vaccines
J & J Single-Shot COVID-19 Vaccine shows Positive Data Against Delta Variant
Demonstrated strong neutralizing antibody activity against the Delta (B.1.617.2) variant Persistent immune responses through at least eight months Jo...
July 04, 2021 | News
Korea (KNIH) conducts field inspection of companies with mRNA technology
Korea National Institute of Health (KNIH), Korea's top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted...
July 02, 2021 | News
InDevR Launches VaxArray Polio Kit
InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeu...
July 01, 2021 | News
Clover Announces Advance Purchase Agreement with Gavi
Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address ...
June 30, 2021 | News
India cleared the 4th vaccine for emergency use in the country, the US-made Moderna.
Mumbai-based pharma major Cipla has been allowed to import Moderna's Covid vaccine for restricted emergency use in India, where the vaccines used so far we...
June 30, 2021 | News
mRNA Vaccine Technology Holds Promise, but Faces Challenges
Numerous studies and statistics from national governments also suggest the data looks good regarding how the mRNA vaccines perform against emerging variant...
June 24, 2021 | Opinion
Merck Receives Patent for Improved CRISPR Genome-Editing Method in Japan
Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions ...
June 23, 2021 | News
eTheRNA and VUB expand strategic collaboration to engineer next generation mRNA therapeutics with TetraMix®
eTheRNA immunotherapies NV a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, announ...
June 23, 2021 | News
Manufacturing Strategies for mRNA Vaccines and Therapeutics
In contrast, non-viral delivery systems are expected to have a better safety profile and with simplified manufacturing, offer the potential for a templated...
June 18, 2021 | News | By Nargisse El Hajjami, Dr1, Manuel Brantner, Mag.2, Anissa Boumlic, Dr3, Shiksha Mantri, 4, Bahar Cebi, 5 1Associate Director Cell and Gene Therapy Segment EMEA, 2Associate Director Vaccine and Plasma Segment EMEA, 3Head of Global Vaccine & Plasma Segments
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy
93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...
June 15, 2021 | News
G7 Summit announces pledges of 870 million COVID-19 vaccine doses
COVAX welcomes dose sharing commitments for 870 million additional doses to support equitable access to vaccines in 2021 and 2022, with the aim to delive...
June 14, 2021 | News
EHA:Efficacy of Pfizer/BioNTech BNT162b2 vaccine in patients receiving CAR-T
The Pfizer/BioNTech BNT162b2 vaccine has been approved for the prevention of coronavirus 2 severe acute respiratory syndrome (SARS-CoV-2) and is recommende...
June 14, 2021 | News
Novavax Announces Positive Data for COVID-19 Beta (B.1.351) Variant Strain Vaccine
Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine - Primates boosted with rS-B.1.351 vacc...
June 12, 2021 | News
FDA Takes Steps to Increase Availability of COVID-19 Vaccine
The agency is announcing today that it is authorizing for use, under the emergency use authorization (EUA) for the Janssen COVID-19 vaccine, two batches of...
June 12, 2021 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
